EP4267184
INTERLEUKIN 5 BINDING PROTEIN DOSAGE REGIMEN
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
20.12.2021EP published:
26.11.2025EP application number:
21844228.3
EPO information:
European Patent Register
Max expiry date:
19.12.2041
Title in English:
INTERLEUKIN 5 BINDING PROTEIN DOSAGE REGIMENLanguage of the patent:
English
Timeline
Today
20.12.2021EP application
26.11.2025EP Publication
Owner
Name:
GlaxoSmithKline Intellectual Property Development LimitedAddress:
GSK Medicines Research Centre Gunnels Wood Road, Stevenage SG1 2NY, GB
Inventor
Name:
AUSTIN, Daren JAddress:
Brentford Middlesex TW8 9GS, GB
Name:
BIRD, Nicholas PAddress:
Stevenage Hertfordshire SG1 2NY, GB
Name:
MONCK, Myrna AAddress:
Collegeville, Pennsylvania 19426, US
Name:
POULIQUEN, Isabelle JAddress:
Brentford Middlesex TW8 9GS, GB
Name:
SHUMAN, Melissa AAddress:
Collegeville, Pennsylvania 19426, US
Priority
Number:
202063128922 PDate:
22.12.2020Country:
US
Number:
202163192854 PDate:
25.5.2021Country:
US
Number:
202163220182 PDate:
9.7.2021Country:
US
Number:
202163285513 PDate:
3.12.2021Country:
US
Classification
Categories:
A61K 39/395, C07K 16/24